Literature DB >> 33423123

ASO Author Reflections: Evidence for Limiting Perioperative Allogenic Blood Transfusions for Patients Undergoing CRS/HIPEC.

Boateng Kubi1, Fabian M Johnston2, Jonathan B Greer2.   

Abstract

Entities:  

Year:  2021        PMID： 33423123     DOI： 10.1245/s10434-020-09531-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  Dose-Dependent Effect of Red Blood Cells Transfusion on Perioperative and Long-Term Outcomes in Peritoneal Surface Malignancies Treated with Cytoreduction and HIPEC.

Authors:  Eran Nizri; Shigeki Kusamura; Giuditta Fallabrino; Marcello Guaglio; Dario Baratti; Marcello Deraco
Journal:  Ann Surg Oncol       Date:  2018-07-26       Impact factor: 5.344

2.  Impact of perioperative blood transfusion on immune function and prognosis in colorectal cancer patients.

Authors:  Li Qiu; Dao-Rong Wang; Xiang-Yun Zhang; Shan Gao; Xiao-Xia Li; Gong-Ping Sun; Xiao-Bo Lu
Journal:  Transfus Apher Sci       Date:  2015-07-20       Impact factor: 1.764

3.  Effect of Perioperative Transfusion on Recurrence and Survival after Gastric Cancer Resection: A 7-Institution Analysis of 765 Patients from the US Gastric Cancer Collaborative.

Authors:  Malcolm H Squires; David A Kooby; George A Poultsides; Sharon M Weber; Mark Bloomston; Ryan C Fields; Timothy M Pawlik; Konstantinos I Votanopoulos; Carl R Schmidt; Aslam Ejaz; Alexandra W Acher; David J Worhunsky; Neil Saunders; Edward A Levine; Linda X Jin; Clifford S Cho; Emily R Winslow; Maria C Russell; Charles A Staley; Shishir K Maithel
Journal:  J Am Coll Surg       Date:  2015-06-21       Impact factor: 6.113

4.  A protocol for management of blood loss in surgical treatment of peritoneal malignancy by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  N Sargant; A Roy; S Simpson; K Chandrakumaran; S Alves; J Coakes; J Bell; J Knight; P Wilson; F Mohamed; T Cecil; B Moran
Journal:  Transfus Med       Date:  2016-03-31       Impact factor: 2.019
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.